SYBLEU INC (SYBE)

USD 0.06

(34.15%)

Long Term Debt Summary of SYBLEU INC

  • SYBLEU INC's latest annual long term debt in 2022 was 300 Thousand USD , down 0.0% from previous year.
  • SYBLEU INC's latest quarterly long term debt in 2023 Q3 was 300 Thousand USD , down 0.0% from previous quarter.
  • SYBLEU INC reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • SYBLEU INC reported annual long term debt of - USD in 2020, down 0.0% from previous year.
  • SYBLEU INC reported quarterly long term debt of 300 Thousand USD for 2023 Q2, down 0.0% from previous quarter.
  • SYBLEU INC reported quarterly long term debt of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SYBLEU INC (2022 - 2019)

Historical Annual Long Term Debt of SYBLEU INC (2022 - 2019)

Year Long Term Debt Long Term Debt Growth
2022 300 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%

Peer Long Term Debt Comparison of SYBLEU INC

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -3650.0%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 82.911%
Qrons Inc. 80 Thousand USD -275.0%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 98.523%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD -75.203%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 98.565%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -411.579%
Mesoblast Limited 100.29 Million USD 99.701%
Marizyme, Inc. 667.12 Thousand USD 55.031%
Genus plc 228.2 Million USD 99.869%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.819%
Therapeutic Solutions International, Inc. 5512.00 USD -5342.671%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 86.425%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 78.616%
IMV Inc. 27.39 Million USD 98.905%
AXIM Biotechnologies, Inc. 5.42 Million USD 94.472%
MultiCell Technologies, Inc. 36.43 USD -823397.118%
ONE Bio Corp. 592.19 Thousand USD 49.341%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.461%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 86.523%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 75.577%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 45.906%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -1085.818%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 84.198%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 6.832%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.997%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -100.0%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -82.698%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 98.046%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -6632.496%
Genscript Biotech Corporation 287.12 Million USD 99.896%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -137.526%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -30.838%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -30.61%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 96.37%
BioStem Technologies, Inc. 265.63 Thousand USD -12.937%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -28095.489%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -100.516%
Regen BioPharma, Inc. 149.61 Thousand USD -100.516%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -112.766%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 96.164%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 18.71%
International Stem Cell Corporation 445 Thousand USD 32.584%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 96.319%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 34.354%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 74.16%
PureTech Health plc 18.25 Million USD 98.356%
Coeptis Therapeutics, Inc. 150 Thousand USD -100.0%
IXICO plc 275 Thousand USD -9.091%
IntelGenx Technologies Corp. 11.83 Million USD 97.466%
Gelesis Holdings, Inc. 26.3 Million USD 98.86%
CSL Limited 11.23 Billion USD 99.997%
Cellectis S.A. 36.21 Million USD 99.172%